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ABSTRACT
This study explored the relationships among genotypes, virulence and clinical forms of Sporothrix
schenckii. Genomic DNA from isolates of S. schenckii, collected from different clinical forms of
sporotrichosis, was ampliﬁed by randomly ampliﬁed polymorphic DNA (RAPD). Suspensions of
different isolates of S. schenckii were inoculated into healthy BALB ⁄ c mice to compare their virulence,
and the numbers and distribution of spores were determined by histological analysis. RAPD analysis
indicated that the isolates from different clinical forms of sporotrichosis belonged to different genotypes.
The mice inoculated with isolates from disseminated sporotrichosis showed an earlier onset of illness
and more severe lesions than those inoculated with isolates from lymphocutaneous sporotrichosis,
which, in turn, showed an earlier onset of illness and more severe lesions than those inoculated with
isolates from ﬁxed cutaneous sporotrichosis. Healthy BALB ⁄ c mice injected with isolates from
disseminated sporotrichosis died within 10 days, whereas isolates from lymphocutaneous sporotricho-
sis and ﬁxed cutaneous sporotrichosis failed to cause death. Histologically, mice inoculated with isolates
from disseminated sporotrichosis had more spores than those inoculated with isolates from lympho-
cutaneous sporotrichosis and ﬁxed cutaneous sporotrichosis. Thus, different genotypes may be
associated closely with the virulence of different clinical forms of S. schenckii infection.
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INTRODUCTION
Sporothrix schenckii is a human pathogen that
causes sporotrichosis, an important mycosis with
a worldwide distribution. Cutaneous sporotricho-
sis is the most common form, including lympho-
cutaneous sporotrichosis (LS) and ﬁxed cutaneous
sporotrichosis (FCS). LS and FCS account for the
majority of clinical cases, and disseminated
sporotrichosis (DS) is infrequent [1–3]. It is well-
known that the clinical form of sporotrichosis
depends on the host’s immune condition [4–6].
DS is reported mostly among immunocompro-
mised hosts, especially AIDS patients [7–11].
Tachibana et al. [12,13] described the characteris-
tic infectivity of S. schenckii in mice and the
immune response against infection, but the poss-
ible relationship between the different genotypes
of S. schenckii and the various clinical forms of
sporotrichosis has not been investigated previ-
ously. Accordingly, the present study investigated
the relationships among genotypes, virulence and
clinical forms of S. schenckii infection.
MATERIALS AND METHODS
Isolates
Fifteen clinical isolates were studied: S. schenckii isolates
DmuD, JD and CZ9784 were from DS; CmuL001, CmuL002,
CmuL003, CmuL004, CmuL005 and CmuL006 were from LS;
and CmuS001, CmuS002, CmuS003, CmuS004, CmuS005 and
CmuS006 were from FCS (Table 1). Isolates were cultured in
300 mL of brain-heart infusion broth (Difco Laboratories,
Detroit, MI, USA) with reciprocal shaking (120 cycles ⁄min) at
37C for 3 days to obtain yeast forms. The cultures were then
ﬁltered though 12 layers of sterile gauze to remove hyphae,
washed three times with phosphate-buffered saline, centri-
fuged at 700 g for 15 min, and stored in 1.0-mL aliquots at
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) 70C until use. Before use, three yeast form preparations
were checked for viable counts by plating 0.1-mL aliquots of
serial dilutions of the samples on Sabouraud dextrose agar and
incubating at room temperature for 3 days. The mean number
of CFU on three plates was determined. The yeast form
suspensions were used to induce infection after dilution to the
required concentration (see below). The concentration of
fungal suspension used for inoculation of mice was recon-
ﬁrmed by plating on Sabouraud dextrose agar.
Animals
Male BALB ⁄ c mice aged 8 weeks (mean weight 24 ± 4 g) were
purchased from the Laboratory Animal Centre of China
Medical University (Shenyang, China). Sixty mice were divi-
ded into ten groups of six mice. All the mice were maintained
in a speciﬁc pathogen-free environment.
Random ampliﬁed polymorphic DNA (RAPD) analysis
Genomic DNA of all the isolates was extracted using cetyltri-
methylammonium bromide (CTAB) as described previously
[14,15]. RAPD analysis was performed in 25-lL reaction mixes
containing 10 ng of sample DNA, 2.5 mmol MgCl2, 200 lmol
dNTPs, 100 pmol of each primer (OPBG-01, 5¢-GTGGCTCTCC;
OPBG-14, 5¢-GACCAGCCCA), and 1 U Taq DNA polymerase
(TaKaRa, Tokyo, Japan). Ampliﬁcation comprised 45 cycles of
1 min at 94C, 1 min at 35C and 1 min at 72C, followed by
7 min at 72C. Following electrophoresis on agarose 2% w ⁄v
gels and staining with ethidium bromide 0.5 mg ⁄L, digital
images were captured with a documentation system and
printed on a digital graphic printer. Each experiment was
repeated three times.
Infection experiments
A control group consisted of six mice. The nine experiment
groups were designated as the footpad groups (F-DS, F-LS and
F-FCS), the venous groups (V-DS, V-LS and V-FCS), and the
peritoneal groups (P-DS, P-LS and P-FCS) (Table 2). In the
footpad groups, 0.05 mL (20 CFU) of suspensions of the yeast
forms of S. schenckii from different clinical forms of sporotri-
chosis were injected into the hind footpad of the mice using a
27-gauge needle and a 1-mL syringe. In the venous groups,
0.2 mL of suspension (3 · 106 CFU) was injected into the
caudal vein of the mice. In the peritoneal groups, the mice
were injected intraperitoneally with 0.2 mL of suspension
(3 · 106 CFU).
Histopathological examination
The infected mice were killed humanely, and then dissected.
The swelling footpads or skin on tails and the visceral organs
were ﬁxed in formalin 10% v ⁄v. Thin (2 lm) parafﬁn sections
were prepared and examined by light microscopy after
staining with periodic acid-Schiff (PAS) stain, as well as with
haematoxylin and eosin (HE).
RESULTS
RAPD analysis
The RAPD patterns obtained using primers
OPBG-01 and OPBG-14 with 15 isolates are
shown in Fig. 1 and summarised in Table 1. The
isolates of S. schenckii from different clinical
forms of sporotrichosis belonged to different
genotypes.
Virulence and infectious features
S. schenckii isolates from different clinical forms of
sporotrichosis were examined for their virulence.
After injection of 20 CFU into footpads, or 3 · 106
CFU into the caudal vein, all mice developed
sporotrichosis. All the mice in the F-DS and V-DS
groups died within 7–10 days and 4–8 days,
respectively. Following intraperitoneal inocula-
Table 1. Random ampliﬁed polymorphic DNA (RAPD)
products of Sporothrix schenckii isolates from different
clinical forms of sporotrichosis
Isolate Clinical form RAPD fragments (bp)
DmuD DS 1800 1400 800 700 520 350 130
JD DS 1800 1400 800 700 520
CZ9784 DS 1800 1400 800 700 520
CmuS001 FCS 2000 800 700 520 300 200
CmuS002 FCS 2000 800 700 520 300 200
CmuS003 FCS 2000 800 600 520 230 200
CmuS004 FCS 2000 800 600 520 230 200
CmuS005 FCS 2000 1000 800 700 520 230 200
CmuS006 FCS 2000 800 600 520 230 200
CmuL001 LS 1400 800 700 520
CmuL002 LS 1400 800 700 600 520
CmuL003 LS 1400 800 700 520
CmuL004 LS 1400 800 700 600 520
CmuL005 LS 1400 800 700 520
CmuL006 LS 1400 800 700 520
DS, disseminated sporotrichosis; FCS, ﬁxed cutaneous sporotrichosis; LS, lympho-
cutaneous sporotrichosis.
Table 2. Numbers of mice inoculated with Sporothrix
schenckii isolates derived from different forms of clinical
infection
Experimental groups
F-DS F-FCS F-LS V-DS V-FCS V-LS P-DS P-FCS P-LS
2 2 2
2 2 2
2 2 2
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
F, footpad; V, venous; P, peritoneal.
DS, disseminated sporotrichosis; FCS, ﬁxed cutaneous sporotrichosis; LS, lympho-
cutaneous sporotrichosis.
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tion of 3 · 106 CFU, all the mice in the P-DS group
died within 7–10 days.
In the F-LS group, all six mice began to
develop footpad swelling and ulcers after 7–
14 days, with two mice developing reddish
swelling and nodules on the skin of the knees.
The lesions began to disappear after 4 weeks
and no mice died. In the V-LS group, all six
mice developed some nodules within 7–10 days,
with reddish swellings and ulcers along the tail.
In the P-LS group, all six mice survived without
lesions.
In the F-FCS group, all six mice developed
footpad swelling at 12–18 days after inoculation,
but no mice died. In the V-FCS group, all six mice
developed several nodules and reddish swellings
of skin along the tail in 12–18 days. In the P-FCS
group, no infection was established in visceral
organs or cutaneous tissues.
Some yellow nodules were observed on the
surface of the livers of all 18 mice inoculated with
isolates from DS, whereas no change in the livers
of the mice inoculated with isolates from LS and
FCS was observed (Table 3).
Fungal culture from murine lesions
Typical fungal colonies were grown from speci-
mens taken from the lesions of footpads, tails and
visceral organs, with moist, white colonies devel-
oping within 3–7 days, after which the surface of
the colonies became wrinkled and folded, and the
colonies turned tan and, ultimately, black. RAPD
analysis of genomic DNA extracted from the
colonies showed that the RAPD patterns were the
same as those of the initial isolates.
Histopathology of lesions from different forms
of sporotrichosis
Footpads of the mice in the F-DS group showed
more PAS-positive, cigar-shaped, round, oval or
elongated, and budding cells in dermis than those
in the footpads of mice in the LS and F-FCS
groups. Table 4 summarises the spore counts for
the footpad groups. There was a signiﬁcant
difference in the average spore count between
the F-DS and F-LS groups, and between the F-LS
and F-FCS groups.
DISCUSSION
Although S. schenchii genotypes have been related
to geographical distribution by previous investi-
gators [16,17], a relationship among genotypes
and various clinical forms of sporotrichosis has
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Fig. 1. Random ampliﬁed polymorphic DNA (RAPD)
analysis of ten isolates of Sporothrix schenckii from different
clinical forms of sporotrichosis (Table 1). Lanes: M,
molecular size marker ladder DL2000; 1, CmuL004; 2,
CmuL003; 3, CmuL002; 4, CmuL001; 5, CmuS004; 6,
CmuS003; 7, CmuS002; 8, CmuS001; 9, CZ9784; 10, DmuD.
Table 3. The number of mice ill or dead after inoculation with suspensions of Sporothrix schenckii obtained from different
clinical forms of spororichosis
Group
Number of mice ill or deada
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
F-DS 1 2 1, 1* 1* 3*
F-LS 1 1 1 2 1
F-FCS 1 1 2 1 1
V-DS 2 2 2* 1* 1*
V-LS 1 2 2 1
V-FCS 1 2 1 1 1
P-DS 1* 2* 2* 1*
P-LS
P-FCS
aFigures denoted *indicate the number of dead mice. Other numbers are the number of mice that were ill.
F, footpad; V, venous; P, peritoneal; DS, disseminated sporotrichosis; FCS, ﬁxed cutaneous sporotrichosis; LS, lymphocutaneous sporotrichosis.
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not been described previously. The present study
found that RAPD patterns of isolates from differ-
ent clinical forms of sporotrichosis formed dis-
tinct genotypes. Initial experiments in which 10
CFU were injected into hind footpads of mice
failed to establish infection within 30 days, indi-
cating, as reported previously [18,19], that most
S. schenckii infections might be sub-clinical. Sub-
sequent footpad experiments with larger inocula
demonstrated that all of the mice inoculated with
isolates from DS died within 7–10 days, whereas
none of the mice inoculated with isolates from
FCS and LS established a systemic infection. The
mice in the F-LS group showed an earlier onset of
illness and more severe lesions than those in the
F-FCS group. Histopathology results showed a
statistically signiﬁcant difference in the number of
spores among the DS, FCS or LS groups, indica-
ting that the virulence of isolates from DS is
greater than that of isolates from LS and FCS. One
possibility is that systemic infection caused by DS
isolates may be associated with thermotolerance
[20].
Similarly, in the venous groups, all the mice in
the DS group died within 8 days, whereas none of
the mice in the FCS or LS groups died. All the
mice in the V-LS group developed illness earlier,
and had more nodules along the tail, than those in
the V-FCS group, as seen also in human LS. In the
V-LS group, it is possible that the injected isolates
of S. schenckii leaked from the caudal vein into the
skin of the tail. In the peritoneal groups, all the
mice injected with DS isolates died within 7–
10 days, whereas none of the mice injected with
FCS or LS isolates died, and no cutaneous or
visceral infection was observed.
Tachibana et al. [12] reported that the proper-
ties of clinical isolates and the routes of infection
are critical for the establishment of systemic
infection, and that genomic differences may result
in different inherent virulence properties for
S. schenckii. The results of the present study
conﬁrm that different clinical forms of sporotri-
chosis are related to the source of isolates, the
route of infection, and the host condition. The fact
that the isolates from different clinical forms of
sporotrichosis belonged to different RAPD geno-
types may be related to virulence. Further work is
required with strains of S. schenckii isolated from
clinical cases of DS.
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